Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...

QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...

Glaucoma is often at a more advanced stage by the time these symptoms appear, underscoring the ldquo;silent nature rdquo; of ...

Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

Open-angle glaucoma is a common eye condition that ... which has been the standard treatment for many years. Several studies have investigated the outcomes of Ex-PRESS implantation in comparison ...

A completely blocked-off drainage angle is called acute angle-closure glaucoma ... The damage caused by glaucoma can’t be ...

Acute angle-closure glaucoma ... Although there is no lasting treatment for glaucoma, early treatment can often control it. There are various medicines that can be used to cause the eye to ...

Risk for acute angle glaucoma. History of increased IOP or open angle glaucoma; monitor closely. Assess family history and evaluate for tics or Tourette’s syndrome before initiating; monitor for ...

Consider discontinuing if new psychotic/manic symptoms occur. Risk for acute angle glaucoma. History of increased IOP or open angle glaucoma; monitor closely. Assess family history and evaluate ...

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

The glaucoma treatment market is set to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR of 3.18%. Open-angle glaucoma remains the most prevalent type, often progressing ...